Profile
Sophia Paspal worked as a Director of Regulatory Affairs & Oncology at Halozyme Therapeutics, Inc. from 2015 to 2017.
Prior to that, she was an Associate Director of Regulatory Affairs & Neurology at Dart NeuroScience LLC in 2014-2015.
Dr. Paspal also served as the Chief Development Officer at Xynomic Pharmaceuticals Holdings, Inc. Dr. Paspal received her undergraduate and doctorate degrees from the University of Minnesota.
Former positions of Sophia Paspal
| Companies | Position | End |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2017 |
Dart NeuroScience LLC
Dart NeuroScience LLC Pharmaceuticals: MajorHealth Technology Develops drugs to improve memory | Corporate Officer/Principal | 01/01/2015 |
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Sophia Paspal
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dart NeuroScience LLC
Dart NeuroScience LLC Pharmaceuticals: MajorHealth Technology Develops drugs to improve memory | Health Technology |
Xynomic Pharmaceuticals Holdings, Inc.
Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and supplies oncology drugs | Health Technology |
- Stock Market
- Insiders
- Sophia Paspal
















